Thyrotrophin releasing hormone (TRH) is a potent stimulus of the release of thyrotrophin (TSH) and prolactin from the anterior pituitary gland of man (Bowers, Friesen, Hwang, Guyda & Folkers, 1971; Jacobs, Snyder, Wilber, Utiger & Daughaday, 1971; L'Hermite, Vanhaelst, Copinschi, Leclercq, Golstein, Bruno & Robyn, 1972; Toft, Boyns, Cole, Groom, Hunter & Irvine, 1973). Whereas the plasma TSH response to intravenous TRH is enhanced in patients with primary hypothyroidism, and abolished in patients with thyrotoxicosis, the relationship between thyroid status and prolactin release by TRH is not clear. Although there is a small increase in plasma prolactin in hypothyroidism (Jacobs et al. 1971; Toft et al. 1973) the response to TRH is not significantly different from that seen in normal subjects (Toft et al. 1973). Recently, Snyder, Jacobs, Utiger & Daughaday (1973) found that when patients with thyroid disease were studied before and after treatment, the prolactin response to TRH
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 1 | 0 | 0 |
PDF Downloads | 2 | 0 | 0 |